331 related articles for article (PubMed ID: 34166776)
1. Repositioning of non-antibiotic drugs as an alternative to microbial resistance: a systematic review.
Foletto VS; da Rosa TF; Serafin MB; Bottega A; Hörner R
Int J Antimicrob Agents; 2021 Sep; 58(3):106380. PubMed ID: 34166776
[TBL] [Abstract][Full Text] [Related]
2. Repositioning of antidepressant drugs and synergistic effect with ciprofloxacin against multidrug-resistant bacteria.
Foletto VS; da Rosa TF; Serafin MB; Bottega A; Franco LN; de Paula BR; Hörner R
World J Microbiol Biotechnol; 2021 Feb; 37(3):53. PubMed ID: 33604693
[TBL] [Abstract][Full Text] [Related]
3. Repurposing Non-Antibiotic Drugs Auranofin and Pentamidine in Combination to Combat Multidrug-Resistant Gram-Negative Bacteria.
Yu Y; Zhao H; Lin J; Li Z; Tian G; Yang YY; Yuan P; Ding X
Int J Antimicrob Agents; 2022 May; 59(5):106582. PubMed ID: 35378227
[TBL] [Abstract][Full Text] [Related]
4. Repurposing Non-Antimicrobial Drugs and Clinical Molecules to Treat Bacterial Infections.
Younis W; Thangamani S; Seleem MN
Curr Pharm Des; 2015; 21(28):4106-11. PubMed ID: 25961308
[TBL] [Abstract][Full Text] [Related]
5. Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria.
Liu Y; Tong Z; Shi J; Li R; Upton M; Wang Z
Theranostics; 2021; 11(10):4910-4928. PubMed ID: 33754035
[TBL] [Abstract][Full Text] [Related]
6. Repurposing of Anticancer Drugs for the Treatment of Bacterial Infections.
Soo VW; Kwan BW; Quezada H; Castillo-Juárez I; Pérez-Eretza B; García-Contreras SJ; Martínez-Vázquez M; Wood TK; García-Contreras R
Curr Top Med Chem; 2017; 17(10):1157-1176. PubMed ID: 27697046
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and characterisation of carbapenemase encoding genes in multidrug-resistant Gram-negative bacilli.
Haji SH; Aka STH; Ali FA
PLoS One; 2021; 16(11):e0259005. PubMed ID: 34723978
[TBL] [Abstract][Full Text] [Related]
8. Drug repurposing to overcome microbial resistance.
Jampilek J
Drug Discov Today; 2022 Jul; 27(7):2028-2041. PubMed ID: 35561965
[TBL] [Abstract][Full Text] [Related]
9. Recent Drug-Repurposing-Driven Advances in the Discovery of Novel Antibiotics.
Konreddy AK; Rani GU; Lee K; Choi Y
Curr Med Chem; 2019; 26(28):5363-5388. PubMed ID: 29984648
[TBL] [Abstract][Full Text] [Related]
10. A review on antimicrobial botanicals, phytochemicals and natural resistance modifying agents from Apocynaceae family: Possible therapeutic approaches against multidrug resistance in pathogenic microorganisms.
Anand U; Nandy S; Mundhra A; Das N; Pandey DK; Dey A
Drug Resist Updat; 2020 Jul; 51():100695. PubMed ID: 32442892
[TBL] [Abstract][Full Text] [Related]
11. Editorial: Beyond Antimicrobials: Non-traditional Approaches to Combating Multidrug-Resistant Bacteria.
Kirienko NV; Rahme L; Cho YH
Front Cell Infect Microbiol; 2019; 9():343. PubMed ID: 31681623
[No Abstract] [Full Text] [Related]
12. Repurposing Screen Identifies Unconventional Drugs With Activity Against Multidrug Resistant
Cheng YS; Sun W; Xu M; Shen M; Khraiwesh M; Sciotti RJ; Zheng W
Front Cell Infect Microbiol; 2018; 8():438. PubMed ID: 30662875
[TBL] [Abstract][Full Text] [Related]
13. Reprogramming of antibiotics to combat antimicrobial resistance.
Dubey KK; Indu ; Sharma M
Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000168. PubMed ID: 32776618
[TBL] [Abstract][Full Text] [Related]
14. Emergence of high drug resistant bacterial isolates from patients with health care associated infections at Jimma University medical center: a cross sectional study.
Gashaw M; Berhane M; Bekele S; Kibru G; Teshager L; Yilma Y; Ahmed Y; Fentahun N; Assefa H; Wieser A; Gudina EK; Ali S
Antimicrob Resist Infect Control; 2018; 7():138. PubMed ID: 30479751
[TBL] [Abstract][Full Text] [Related]
15. The Antibacterial Activity of Metal Complexes Containing 1,10- phenanthroline: Potential as Alternative Therapeutics in the Era of Antibiotic Resistance.
Viganor L; Howe O; McCarron P; McCann M; Devereux M
Curr Top Med Chem; 2017; 17(11):1280-1302. PubMed ID: 27697043
[TBL] [Abstract][Full Text] [Related]
16. Synergistic combinations of anthelmintic salicylanilides oxyclozanide, rafoxanide, and closantel with colistin eradicates multidrug-resistant colistin-resistant Gram-negative bacilli.
Domalaon R; Okunnu O; Zhanel GG; Schweizer F
J Antibiot (Tokyo); 2019 Aug; 72(8):605-616. PubMed ID: 31028351
[TBL] [Abstract][Full Text] [Related]
17. Improving the treatment of bacterial infections caused by multidrug-resistant bacteria through drug repositioning.
Glajzner P; Bernat A; Jasińska-Stroschein M
Front Pharmacol; 2024; 15():1397602. PubMed ID: 38910882
[TBL] [Abstract][Full Text] [Related]
18. Anthelmintic Drugs for Repurposing against Gram-Negative Bacilli Infections.
Canturri AM; Smani Y
Curr Med Chem; 2022; 30(1):59-71. PubMed ID: 35838224
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections.
Copp JN; Pletzer D; Brown AS; Van der Heijden J; Miton CM; Edgar RJ; Rich MH; Little RF; Williams EM; Hancock REW; Tokuriki N; Ackerley DF
mBio; 2020 Sep; 11(5):. PubMed ID: 32934086
[TBL] [Abstract][Full Text] [Related]
20. The Potential of Antibiotics and Nanomaterial Combinations as Therapeutic Strategies in the Management of Multidrug-Resistant Infections: A Review.
Adeniji OO; Nontongana N; Okoh JC; Okoh AI
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
